- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Diane Scott: Canadian Firms Can Help Developing Medical Cannabis Markets
Diane Scott, CEO of JMCC, talks about weighing the decision to go public and the benefits of private cannabis investing.
The public markets have offered the cannabis industry an avenue for direct growth and business impact. However, as the industry matures private companies are creating alternative options.
The Investing News Network (INN) talked with Diane Scott, CEO of Jamaican Medical Cannabis Corporation (JMCC), about the role of the private sector within the cannabis space at the Lift & Co. (TSXV:LIFT) cannabis expo in Vancouver.
Most recently, JMCC increased its production capacity in Jamaica. This acquisition will produce a minimum of three harvests per year of medical cannabis.
In an update, the company indicated that during its Q2 2019 it will incorporate an analytical testing lab, as well as processing, extraction, packaging, warehousing and logistics operations. JMCC expects to get inspected for a GMP certification by the end of the period.
As part of the conversation at Lift, Scott broke down the role Canadian firms have in terms of the rest of the world opening to the medical cannabis market.
Speaking in a panel at the business conference portion of the expo, Scott explained that Canadian companies are able to impart knowledge in emerging markets.
“There is a real opportunity in my opinion for Canadian [licensed producers] to have high-quality product to go to these places and import the Canadian product, and quite frankly the Canadian learning and experience, which is a win,” Scott told INN.
Private investment in cannabis market
JMCC is a private venture, and Scott wants to keep it that way — the executive confirmed that despite hearing from potential investors she has no plans to take JMCC public any time soon.
“We’re not going to seek an IPO any time in the near future, but I completely understand the rush that comes with becoming a public company — almost the wooing of the public market,” Scott said.
Codie Sanchez, an investor and partner with CS Ventures, previously told INN that private players are moving closer to the cannabis space in the US. She predicts that venture capital and private equity firms will enter the cannabis market more aggressively.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.